Cannabix Delivers Marijuana Breath Test to Virginia Industrial Manufacturer

Event summary

  • Cannabix Technologies delivered its Marijuana Breath Test (MBT) to a Virginia-based industrial manufacturing client on April 1, 2026.
  • The client operates large-scale custom machinery fabrication and sought a non-invasive method to assess recent cannabis use among its workforce.
  • The MBT system detects delta-9 THC in breath within four hours of use, aligning with recent-use effects.
  • Cannabix partners with Omega Laboratories, a global leader in forensic drug testing, for laboratory analysis.

The big picture

Cannabix's delivery of the MBT to a Virginia industrial manufacturer highlights the growing need for non-invasive, recent-use cannabis testing in safety-sensitive workplaces. The industrial manufacturing sector faces increasing challenges related to cannabis use, including higher rates of workplace injuries and outdated testing methods. This delivery marks another step in Cannabix's commercialization strategy, reinforcing its competitive position within safety-sensitive industries.

What we're watching

Market Adoption
The pace at which industrial manufacturers adopt the MBT system will indicate its commercial viability.
Regulatory Compliance
Whether the MBT can meet evolving legal and policy conflicts resulting from state-level cannabis legalization.
Competitive Positioning
How Cannabix's strategic partnership with Omega Laboratories will enhance its competitive edge in the cannabis testing market.